Drugmaker Halves Price of Potentially Promising Coronavirus Treatment
New Jersey-based Rising Pharmaceuticals doubled the price of chloroquine in 2019, but the drugmaker, in response to the coronavirus pandemic, [...]
Blog Post Mulls Indirect Benefits in Value Assessments
A recent blog post published on Health Affairs highlights some key reasons why indirect benefits should be factored into value [...]
IDC, Ponemon Talk Cloud, Security
While managing health claims data can be a complex issue, Ponemon Institute Founder Larry Ponemon told Healthcare IT News cloud-based [...]
Pharma Responds to Canadian Pricing Regulations
Pharmaceutical companies are changing their business interests in Canada following new pricing regulations, according to a Pink Sheet report. According [...]
Predictions for RWE in 2020
A recent article published on PharmaTimes looks at what the future may hold for real-world evidence amid rising interest in [...]
Lin: Clinical Practice Guidelines Not Broken
Family physician and Common Sense Family Doctor blogger Kenneth Lin in a recent post published on MedPage Today writes that [...]
PRMA’s Clayton-Welch: How to Work ‘Smarter’ in Current Climate
PRMA International Experts Group Head Sophie Clayton-Welch outlines five ways pharma and biotech professionals can keep their edge in the [...]
Avalere Health’s Kilgore Talks RWD, CAR T-Cell Therapy
Avalere Health Senior Research Analyst Karl Kilgore in a recent interview with the American Journal of Managed Care (AJMC) discusses [...]
Going Below the Surface Highlights Health Spending
Going Below the Surface, a National Pharmaceutical Council initiative launched in 2018, in a recent newsletter highlights health care spending [...]
Kentucky Governor Bolsters Pharmacist Prescribing Rights Amid Outbreak
Kentucky Gov. Andy Beshear in a new executive order has given the state's pharmacists the ability to fill prescriptions for [...]
NICE Taps Leng as New Chief Executive
The U.K.'s National Institute for Health and Care Excellence (NICE) announced the appointment of Gillian Leng, NICE's current deputy chief [...]
ICER Releases Draft Report on NASH Drug
The Institute for Clinical and Economic Review (ICER) released a draft evidence report on Intercept Pharmaceuticals' obeticholic acid for the [...]
Vogenberg Talks Digital Health Tools
The latest Relentless Health Value podcast features Institute for Integrated Health Principal Randy Vogenberg, who discusses the selection of digital [...]
Webinar to Highlight AMGA’s Efforts to Reduce Low-Value Care
An upcoming webinar is set to outline how AMGA is working to reduce low-value care, a problem which it says [...]
Blog Highlights Report on Coronavirus Medical Costs
A recent Health Populi blog post highlights a new report from the Peterson-KFF Health System Tracker which estimates the average [...]
Opinion: COVID-19 May Prove to be ‘Evidence Fiasco’
The author of a recent opinion piece published on STAT says that while COVID-19 has been branded a once-in-a-century pandemic, [...]
ICER Indefinitely Postpones Public Meetings, Expands Assessment Timelines
In response to the COVID-19 pandemic, the Institute for Clinical and Economic Review (ICER) announced it would indefinitely postpone several [...]
FiercePharma Offering Live Updates to Coronavirus
FiercePharma is offering live updates of the coronavirus, as well as the goings-on in the pharmaceutical industry amid the outbreak. [...]
AMCP Cancels Annual Meeting
The Academy of Managed Care Pharmacy (AMCP) has canceled its annual meeting, which was set to begin April 21, saying [...]
Beijing Investigating Woman Who Entered Country with COVID-19 Symptoms
Beijing authorities have opened an investigation into a woman, surnamed Li, who reportedly entered China to attend a company meeting [...]
Pfizer Offers Its Resources in Fight Against Coronavirus
Pfizer is entering the fight against coronavirus after announcing it would offer its resources for wider use, FiercePharma reports. The [...]
ICER Posts Reports Outlining Two Planned Reviews
The Institute for Clinical and Economic Review (ICER) on Friday, March 13, posted two new draft scoping documents outlining planned [...]
U.S. Looks to Limit Out-of-Pocket Costs for Insulin Under Medicare
The Trump administration announced a new plan to limit the out-of-pocket costs for insulin to $35 month for Medicare patients, [...]
Report Highlights Payer Challenges of Specialized Cancer Treatments
A new FirstWord report takes a deep dive into the payer's perspective on specialized cancer treatments to reveal how pharmaceutical [...]
RWE 2020 Postponed Until Later This Year
The Real-World Evidence 2020: Rare Diseases and Innovative Therapies event has been postponed to later this year in response to [...]